Clinical Trial: Study of AZD9829 in CD123+ Hematological Malignancies
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Hematological Malignancies
Study Type: INTERVENTIONAL
Official Title: A Modular Phase I/II, Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of AZD9829 as Monotherapy or in Combination in Patients
Brief Summary:
This is a modular, multicentre, open-label, Phase I/II, dose-setting study.AZD9829 will be administered intravenously as monotherapy or in combination in participants with CD123 positive hematological malignancies.
Read more